Arizona State University

[Sidebar#SC145549] Biopharmaceutical companies and other life science start-ups may access $1.28bn in new venture capital available through four different sources, including Eir Venture Partners AB’s

Derived from Strategic Transactions , Informa's premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

Third Rock Ventures LLC launched more than 50 biopharma, device and diagnostic companies with its first four venture capital funds, and with its fifth and largest – the $770m Third Rock Ventures V LP

IN VITRO DIAGNOSTICS Enigma Diagnostics Ltd. Enigma Diagnostics gets $50mm through financing arrangement with Shanghai Debay Enigma Diagnostics Ltd. (point-of-care molecular diagnostics) raise